These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 38865038)

  • 1. Toward an international standardisation roadmap for nanomedicine.
    Caputo F; Favre G; Borchard G; Calzolai L; Fisicaro P; Frejafon E; Günday-Türeli N; Koltsov D; Minelli C; Nelson BC; Parot J; Prina-Mello A; Zou S; Ouf FX
    Drug Deliv Transl Res; 2024 Sep; 14(9):2578-2588. PubMed ID: 38865038
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A roadmap to strengthen standardisation efforts in risk governance of nanotechnology.
    Rasmussen K; Bleeker EAJ; Baker J; Bouillard J; Fransman W; Kuhlbusch TAJ; Resch S; Sergent JA; Soeteman-Hernandez LG; Suarez-Merino B; Porcari A
    NanoImpact; 2023 Oct; 32():100483. PubMed ID: 37734653
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A research roadmap for complementary and alternative medicine - what we need to know by 2020.
    Fischer F; Lewith G; Witt CM; Linde K; von Ammon K; Cardini F; Falkenberg T; Fønnebø V; Johannessen H; Reiter B; Uehleke B; Weidenhammer W; Brinkhaus B
    Forsch Komplementmed; 2014; 21(2):e1-16. PubMed ID: 24851850
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Collaborative study for the establishment of the WHO 3(rd) International Standard for Endotoxin, the Ph. Eur. endotoxin biological reference preparation batch 5 and the USP Reference Standard for Endotoxin Lot H0K354.
    Findlay L; Desai T; Heath A; Poole S; Crivellone M; Hauck W; Ambrose M; Morris T; Daas A; Rautmann G; Buchheit KH; Spieser JM; Terao E
    Pharmeur Bio Sci Notes; 2015; 2015():73-98. PubMed ID: 26830160
    [TBL] [Abstract][Full Text] [Related]  

  • 5. From the History of the Croatian Dermatovenereological Society - The Croatian Medical Association and an Overview of Important Information Regarding the Journal Acta Dermatovenerologica Croatica.
    Dobrić I
    Acta Dermatovenerol Croat; 2018 Dec; 26(4):344-348. PubMed ID: 30665489
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methodological needs in the quality and safety characterisation of nanotechnology-based health products: Priorities for method development and standardisation.
    Halamoda-Kenzaoui B; Vandebriel RJ; Howarth A; Siccardi M; David CAW; Liptrott NJ; Santin M; Borgos SE; Bremer-Hoffmann S; Caputo F
    J Control Release; 2021 Aug; 336():192-206. PubMed ID: 34126169
    [TBL] [Abstract][Full Text] [Related]  

  • 7. European and international standardisation progress in the field of engineered nanoparticles.
    Rivière G
    Inhal Toxicol; 2009 Jul; 21 Suppl 1():2-7. PubMed ID: 19558227
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bridging communities in the field of nanomedicine.
    Halamoda-Kenzaoui B; Baconnier S; Bastogne T; Bazile D; Boisseau P; Borchard G; Borgos SE; Calzolai L; Cederbrant K; Di Felice G; Di Francesco T; Dobrovolskaia MA; Gaspar R; Gracia B; Hackley VA; Leyens L; Liptrott N; Park M; Patri A; Roebben G; Roesslein M; Thürmer R; Urbán P; Zuang V; Bremer-Hoffmann S
    Regul Toxicol Pharmacol; 2019 Aug; 106():187-196. PubMed ID: 31051191
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mapping of the available standards against the regulatory needs for nanomedicines.
    Halamoda-Kenzaoui B; Holzwarth U; Roebben G; Bogni A; Bremer-Hoffmann S
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2019 Jan; 11(1):e1531. PubMed ID: 29923692
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Asymmetric-flow field-flow fractionation for measuring particle size, drug loading and (in)stability of nanopharmaceuticals. The joint view of European Union Nanomedicine Characterization Laboratory and National Cancer Institute - Nanotechnology Characterization Laboratory.
    Caputo F; Mehn D; Clogston JD; Rösslein M; Prina-Mello A; Borgos SE; Gioria S; Calzolai L
    J Chromatogr A; 2021 Jan; 1635():461767. PubMed ID: 33310281
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anniversary Oncology Days in Paris.
    Baltaga R
    Exp Oncol; 2023 Dec; 45(3):273-274. PubMed ID: 38186028
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Innovation Partnership for a Roadmap on Vaccines in Europe (IPROVE): A vision for the vaccines of tomorrow.
    Medaglini D; De Azero MR; Leroy O; Bietrix F; Denoel P
    Vaccine; 2018 Feb; 36(9):1136-1145. PubMed ID: 29395517
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fighting trafficking of falsified and substandard medicinal products in Russia.
    Fayzrakhmanov NF
    Int J Risk Saf Med; 2015; 27 Suppl 1():S37-40. PubMed ID: 26639702
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Public-private partnership models in France and in Europe.
    Demotes-Mainard J; Canet E; Segard L
    Therapie; 2006; 61(4):325-34, 313-23. PubMed ID: 17124948
    [TBL] [Abstract][Full Text] [Related]  

  • 16. "Eurocode International Blood Labeling System" enables unique identification of all biological products from human origin in accordance with the European Directive 2004/23/EC.
    Knels R; Mönig HJ; Wittmann G; von Versen R; Pruss A
    Cell Tissue Bank; 2010 Nov; 11(4):345-52. PubMed ID: 20563859
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Future of TABST and LABST in the Indian Pharmacopoeia Monographs A Humane Society International/India Workshop Report.
    Poojary B; Viviani L; Sengupta A; Kalaivani M; Verma SR; Teng V; Makhija V; Prakash R; Bhatia N; Singh SN; Bruckner L; Halder M; Vree J
    Biologicals; 2023 Aug; 83():101665. PubMed ID: 37244127
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulatory insights into nanomedicine and gene vaccine innovation: Safety assessment, challenges, and regulatory perspectives.
    Souto EB; Blanco-Llamero C; Krambeck K; Kiran NS; Yashaswini C; Postwala H; Severino P; Priefer R; Prajapati BG; Maheshwari R
    Acta Biomater; 2024 May; 180():1-17. PubMed ID: 38604468
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Collaborative study for the standardisation of the histamine sensitizing test in mice and the CHO cell-based assay for the residual toxicity testing of acellular pertussis vaccines.
    Xing D; Maes A; Behr-Gross ME; Costanzo A; Daas A; Buchheit KH
    Pharmeur Bio Sci Notes; 2010 Apr; 2010(1):51-63. PubMed ID: 20223190
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Standardisation of defined approaches for skin sensitisation testing to support regulatory use and international adoption: position of the International Cooperation on Alternative Test Methods.
    Casati S; Aschberger K; Barroso J; Casey W; Delgado I; Kim TS; Kleinstreuer N; Kojima H; Lee JK; Lowit A; Park HK; Régimbald-Krnel MJ; Strickland J; Whelan M; Yang Y; Zuang V
    Arch Toxicol; 2018 Feb; 92(2):611-617. PubMed ID: 29127450
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.